Covid has given UK biotech a lesson — and a legacy
The writer was chair of the UK Vaccine Taskforce and is managing partner of SV Health Investors The emergence of a new coronavirus variant, Omicron, is an advent gift no one wants. But we are not facing it unarmed. Unlike last Christmas, we now have a well-advanced vaccine and booster programme in the UK. A recent…
Read more